These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7001203)

  • 1. [Threshold of action of meproscillarin following intravenous administration].
    Belz GG; Aust PE
    Med Klin; 1980 Jul; 75(15):551-3. PubMed ID: 7001203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative dose-effect study with cardiac glycosides assessing cardiac and extracardiac responses in normal subjects.
    Alken RG; Belz GG
    J Cardiovasc Pharmacol; 1984; 6(4):634-40. PubMed ID: 6206318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meproscillarin in patients with renal failure and concomitant heart failure (author's transl)].
    Beckmann H; Belz GG; Quellhorst E
    Med Klin; 1979 Nov; 74(47):1761-6. PubMed ID: 522817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of proscillaridin-4'-methylether on pressure rise velocity in the left ventricle of patients with coronary heart disease (author's transl)].
    Stauch M; Grewe N; Belz GG
    Klin Wochenschr; 1977 Jul; 55(14):705-6. PubMed ID: 330937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma concentration and elimination behavior of the cardiac glycoside meproscillarin in patients with liver cirrhosis].
    Burkert K; Beckmann H
    Z Gastroenterol; 1983 Jan; 21(1):34-40. PubMed ID: 6845784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cardiac beta1- or beta2-adrenergic receptor stimulation and the negative chronotropic effect of low-dose pirenzepine.
    Jakubetz J; Schmuck S; Wochatz G; Ruhland B; Poller U; Radke J; Brodde OE
    Clin Pharmacol Ther; 2000 May; 67(5):549-57. PubMed ID: 10824634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac effects of a single daily dose of 0.15 mg and 0.20 mg of beta-methyldigoxin].
    Belz GG; Wintrich R
    Z Kardiol; 1984 Jan; 73(1):29-33. PubMed ID: 6367246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [14,15-beta-oxido analog of proscillaridin (HOE 040). A new cardiac glycoside with low arrhythmic activity and greater absorption ratio].
    Lindner E; von Reitzenstein G; Schöne HH
    Arzneimittelforschung; 1979; 29(2):221-6. PubMed ID: 109100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative measurement of pulmonary artery pressure after meproscillarin and beta-methyldigoxin demonstrating their effects on the left bentricular function in patients with heart and coronary insufficiency].
    Stauch M; Nissen N; Grewe N
    Arzneimittelforschung; 1978; 28(3a):545-50. PubMed ID: 580586
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasma levels and electrocardiogram after intravenous administration of proscillaridin and digoxin].
    Belz GG; Rudofsky G; Lossnitzer K; Wolf G; Sauch M
    Z Kardiol; 1974 Mar; 63(3):201-11. PubMed ID: 4471866
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect and plasma level of methylproscillaridin and beta-acetyldigitoxin following long term administration in man].
    Belz GG; Nübling H; Strauch M
    Verh Dtsch Ges Kreislaufforsch; 1975; 41():315-9. PubMed ID: 821263
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enteral availability and therapeutic activity of proscillaridin-4'-methyl ether (author's transl)].
    Krämer KD; Hochrein H
    Arzneimittelforschung; 1976 Apr; 26(4):579-83. PubMed ID: 989015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations during repeated intravenous and oral methyl-proscillaridin application in man.
    Belz GG; Nübling H; Belz G
    Arzneimittelforschung; 1976 Feb; 26(2):277-8. PubMed ID: 947212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacodynamics of betamethyl digoxin and digoxin in man.
    Das GP; Talmers RN; Weissler AM
    Clin Pharmacol Ther; 1977 Sep; 22(3):280-5. PubMed ID: 891096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bioavailability of methylepoxyproscillaridin (P35): a new semisynthetic cardiac glycoside.
    Bonelli J; Waginger W; Gazo F
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):297-9. PubMed ID: 3410606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failure.
    Põder P; Eha J; Sundberg S; Antila S; Heinpalu M; Loogna I; Planken U; Rantanen S; Lehtonen L
    Int J Clin Pharmacol Ther; 2003 Aug; 41(8):365-73. PubMed ID: 12940594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of action of beta-methyldigoxin and digoxin utilizing systolic time intervals.
    Katdare AD; Namjoshi SA; Nair KG
    J Int Med Res; 1980; 8(1):50-5. PubMed ID: 7358204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies of action in cats of intraintestinally administered digoxin, proscillardin and K- strophantoside].
    Wójcicki J; Stanosz S
    Acta Pol Pharm; 1977; 34(4):431-3. PubMed ID: 930618
    [No Abstract]   [Full Text] [Related]  

  • 20. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.